Drug Profile
WAY 151616
Alternative Names: KCO 616Latest Information Update: 25 Oct 2005
Price :
$50
*
At a glance
- Originator Wyeth
- Class
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Urinary incontinence
Most Recent Events
- 25 Oct 2005 Discontinued - Preclinical for Urinary incontinence in USA (unspecified route)
- 27 Mar 2002 American Home Products and its subsidiaries Wyeth-Ayerst and Wyeth Lederle are both now called Wyeth
- 09 Nov 2000 Profile reviewed but no significant changes made